Can Spruce Biosciences prove its Sanfilippo treatment slows brain decline? New data could strengthen its FDA case
Spruce Biosciences prepares MPS IIIB disease progression data as TA-ERT approaches its FDA filing and confirmatory trial milestones.
Pharma & Biotech